# BENLYSTA

NDC: 49401-102
Generic name: belimumab
Labeler / Manufacturer: GlaxoSmithKline LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20110310

FDA application: BLA125370

## Active ingredients

- BELIMUMAB: 400 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49401-102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49401-102
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2fa3c528-1777-4628-8a55-a69dae2381a3